nodes	percent_of_prediction	percent_of_DWPC	metapath
Terlipressin—Skin necrosis—Carmustine—melanoma	0.01	0.077	CcSEcCtD
Terlipressin—Atrial fibrillation—Vemurafenib—melanoma	0.00507	0.039	CcSEcCtD
Terlipressin—Skin exfoliation—Bleomycin—melanoma	0.00383	0.0294	CcSEcCtD
Terlipressin—Respiratory failure—Temozolomide—melanoma	0.00344	0.0265	CcSEcCtD
Terlipressin—Skin exfoliation—Carmustine—melanoma	0.00334	0.0257	CcSEcCtD
Terlipressin—Skin exfoliation—Temozolomide—melanoma	0.00323	0.0248	CcSEcCtD
Terlipressin—Cardiac disorder—Vemurafenib—melanoma	0.00308	0.0237	CcSEcCtD
Terlipressin—Angiopathy—Vemurafenib—melanoma	0.00301	0.0232	CcSEcCtD
Terlipressin—Malnutrition—Vemurafenib—melanoma	0.00289	0.0222	CcSEcCtD
Terlipressin—Hot flush—Temozolomide—melanoma	0.00262	0.0202	CcSEcCtD
Terlipressin—Menopausal symptoms—Temozolomide—melanoma	0.0026	0.02	CcSEcCtD
Terlipressin—Hyponatraemia—Carmustine—melanoma	0.00255	0.0196	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Vemurafenib—melanoma	0.00245	0.0188	CcSEcCtD
Terlipressin—Nervous system disorder—Vemurafenib—melanoma	0.00232	0.0178	CcSEcCtD
Terlipressin—Skin disorder—Vemurafenib—melanoma	0.00229	0.0176	CcSEcCtD
Terlipressin—Respiratory failure—Docetaxel—melanoma	0.00229	0.0176	CcSEcCtD
Terlipressin—Acute coronary syndrome—Bleomycin—melanoma	0.00221	0.017	CcSEcCtD
Terlipressin—Myocardial infarction—Bleomycin—melanoma	0.0022	0.0169	CcSEcCtD
Terlipressin—Skin exfoliation—Docetaxel—melanoma	0.00215	0.0165	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Vemurafenib—melanoma	0.00204	0.0157	CcSEcCtD
Terlipressin—Pulmonary oedema—Docetaxel—melanoma	0.002	0.0154	CcSEcCtD
Terlipressin—Hot flush—Docetaxel—melanoma	0.00175	0.0134	CcSEcCtD
Terlipressin—Menopausal symptoms—Docetaxel—melanoma	0.00173	0.0133	CcSEcCtD
Terlipressin—Atrial fibrillation—Docetaxel—melanoma	0.00172	0.0132	CcSEcCtD
Terlipressin—Cardiac failure—Docetaxel—melanoma	0.00167	0.0129	CcSEcCtD
Terlipressin—Hyponatraemia—Docetaxel—melanoma	0.00164	0.0126	CcSEcCtD
Terlipressin—Diarrhoea—Vemurafenib—melanoma	0.00162	0.0124	CcSEcCtD
Terlipressin—Cardiac disorder—Temozolomide—melanoma	0.00158	0.0121	CcSEcCtD
Terlipressin—Angiopathy—Temozolomide—melanoma	0.00154	0.0118	CcSEcCtD
Terlipressin—Malnutrition—Carmustine—melanoma	0.00153	0.0118	CcSEcCtD
Terlipressin—Vomiting—Vemurafenib—melanoma	0.0015	0.0115	CcSEcCtD
Terlipressin—Chest pain—Bleomycin—melanoma	0.00149	0.0115	CcSEcCtD
Terlipressin—Headache—Vemurafenib—melanoma	0.00148	0.0114	CcSEcCtD
Terlipressin—Malnutrition—Temozolomide—melanoma	0.00148	0.0114	CcSEcCtD
Terlipressin—Nausea—Vemurafenib—melanoma	0.0014	0.0108	CcSEcCtD
Terlipressin—Hypertension—Carmustine—melanoma	0.00132	0.0102	CcSEcCtD
Terlipressin—Chest pain—Carmustine—melanoma	0.0013	0.01	CcSEcCtD
Terlipressin—Hypertension—Temozolomide—melanoma	0.00128	0.00981	CcSEcCtD
Terlipressin—Dyspnoea—Bleomycin—melanoma	0.00128	0.0098	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00125	0.00961	CcSEcCtD
Terlipressin—Acute coronary syndrome—Docetaxel—melanoma	0.00124	0.00953	CcSEcCtD
Terlipressin—Myocardial infarction—Docetaxel—melanoma	0.00123	0.00948	CcSEcCtD
Terlipressin—Tachycardia—Carmustine—melanoma	0.00122	0.00937	CcSEcCtD
Terlipressin—Nervous system disorder—Temozolomide—melanoma	0.00118	0.0091	CcSEcCtD
Terlipressin—Skin disorder—Temozolomide—melanoma	0.00117	0.00901	CcSEcCtD
Terlipressin—Dyspnoea—Carmustine—melanoma	0.00111	0.00856	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Carmustine—melanoma	0.00108	0.00829	CcSEcCtD
Terlipressin—Dyspnoea—Temozolomide—melanoma	0.00108	0.00827	CcSEcCtD
Terlipressin—Abdominal pain—Dactinomycin—melanoma	0.00105	0.00811	CcSEcCtD
Terlipressin—Cardiac disorder—Docetaxel—melanoma	0.00105	0.00806	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Temozolomide—melanoma	0.00104	0.00801	CcSEcCtD
Terlipressin—Angiopathy—Docetaxel—melanoma	0.00102	0.00788	CcSEcCtD
Terlipressin—Abdominal pain—Carmustine—melanoma	0.000987	0.00759	CcSEcCtD
Terlipressin—Malnutrition—Docetaxel—melanoma	0.000983	0.00756	CcSEcCtD
Terlipressin—Abdominal pain—Temozolomide—melanoma	0.000954	0.00733	CcSEcCtD
Terlipressin—Diarrhoea—Dactinomycin—melanoma	0.000913	0.00702	CcSEcCtD
Terlipressin—Vomiting—Bleomycin—melanoma	0.000909	0.00699	CcSEcCtD
Terlipressin—Diarrhoea—Carmustine—melanoma	0.000854	0.00657	CcSEcCtD
Terlipressin—Nausea—Bleomycin—melanoma	0.00085	0.00653	CcSEcCtD
Terlipressin—Hypertension—Docetaxel—melanoma	0.000849	0.00652	CcSEcCtD
Terlipressin—Vomiting—Dactinomycin—melanoma	0.000848	0.00652	CcSEcCtD
Terlipressin—Chest pain—Docetaxel—melanoma	0.000837	0.00643	CcSEcCtD
Terlipressin—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.000831	0.00639	CcSEcCtD
Terlipressin—Diarrhoea—Temozolomide—melanoma	0.000826	0.00635	CcSEcCtD
Terlipressin—Vomiting—Carmustine—melanoma	0.000794	0.0061	CcSEcCtD
Terlipressin—Nausea—Dactinomycin—melanoma	0.000792	0.00609	CcSEcCtD
Terlipressin—Nervous system disorder—Docetaxel—melanoma	0.000787	0.00605	CcSEcCtD
Terlipressin—Tachycardia—Docetaxel—melanoma	0.000783	0.00602	CcSEcCtD
Terlipressin—Headache—Carmustine—melanoma	0.000782	0.00601	CcSEcCtD
Terlipressin—Skin disorder—Docetaxel—melanoma	0.000779	0.00599	CcSEcCtD
Terlipressin—Vomiting—Temozolomide—melanoma	0.000767	0.0059	CcSEcCtD
Terlipressin—Headache—Temozolomide—melanoma	0.000756	0.00581	CcSEcCtD
Terlipressin—Nausea—Carmustine—melanoma	0.000742	0.0057	CcSEcCtD
Terlipressin—Nausea—Temozolomide—melanoma	0.000717	0.00551	CcSEcCtD
Terlipressin—Dyspnoea—Docetaxel—melanoma	0.000715	0.0055	CcSEcCtD
Terlipressin—Gastrointestinal disorder—Docetaxel—melanoma	0.000693	0.00532	CcSEcCtD
Terlipressin—Abdominal pain—Docetaxel—melanoma	0.000634	0.00488	CcSEcCtD
Terlipressin—Diarrhoea—Docetaxel—melanoma	0.000549	0.00422	CcSEcCtD
Terlipressin—Vomiting—Docetaxel—melanoma	0.00051	0.00392	CcSEcCtD
Terlipressin—Headache—Docetaxel—melanoma	0.000503	0.00386	CcSEcCtD
Terlipressin—Nausea—Docetaxel—melanoma	0.000477	0.00366	CcSEcCtD
Terlipressin—AVPR2—Signaling by GPCR—RAC1—melanoma	0.000334	0.000384	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EDNRB—melanoma	0.000333	0.000383	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CD86—melanoma	0.000332	0.000382	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—CXCL8—melanoma	0.000332	0.000382	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EDN1—melanoma	0.00033	0.000379	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTK2B—melanoma	0.000326	0.000375	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTK2B—melanoma	0.000324	0.000372	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FGF1—melanoma	0.000322	0.000371	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CSF2—melanoma	0.000322	0.000371	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—IL2—melanoma	0.000318	0.000365	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GNA11—melanoma	0.000317	0.000365	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GAB2—melanoma	0.000317	0.000365	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FLT1—melanoma	0.000316	0.000363	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—E2F1—melanoma	0.000315	0.000363	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GAB2—melanoma	0.000315	0.000362	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GNA11—melanoma	0.000315	0.000362	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CB—melanoma	0.000314	0.000361	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FLT1—melanoma	0.000313	0.00036	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CG—melanoma	0.000313	0.00036	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PDGFRA—melanoma	0.000312	0.000359	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CG—melanoma	0.000311	0.000357	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PRKCA—melanoma	0.000309	0.000355	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ITGB3—melanoma	0.000309	0.000355	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—SPP1—melanoma	0.000303	0.000348	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAP2K2—melanoma	0.000302	0.000347	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—CXCL8—melanoma	0.000302	0.000347	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HDAC2—melanoma	0.000298	0.000343	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCR4—melanoma	0.000298	0.000343	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FOXO4—melanoma	0.000298	0.000343	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HDAC2—melanoma	0.000296	0.00034	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FOXO4—melanoma	0.000296	0.00034	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCR4—melanoma	0.000296	0.00034	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—GNAQ—melanoma	0.000295	0.000339	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—GNAQ—melanoma	0.000293	0.000336	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL2—melanoma	0.000288	0.000331	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TERT—melanoma	0.000287	0.00033	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—RAC1—melanoma	0.000286	0.000329	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CG—melanoma	0.000284	0.000326	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CG—melanoma	0.000282	0.000324	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SYK—melanoma	0.000277	0.000319	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SYK—melanoma	0.000275	0.000316	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CD—melanoma	0.000275	0.000316	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HIF1A—melanoma	0.000275	0.000316	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CD—melanoma	0.000273	0.000314	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NGFR—melanoma	0.000272	0.000313	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ITGAV—melanoma	0.000272	0.000313	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT3—melanoma	0.000272	0.000313	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NGFR—melanoma	0.00027	0.000311	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT3—melanoma	0.00027	0.000311	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ITGAV—melanoma	0.00027	0.000311	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KDR—melanoma	0.000263	0.000302	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FN1—melanoma	0.000253	0.000291	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SOCS1—melanoma	0.000252	0.00029	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAP2K1—melanoma	0.000251	0.000289	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—S100B—melanoma	0.000251	0.000289	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SOCS1—melanoma	0.00025	0.000288	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CD—melanoma	0.00025	0.000287	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAP2K1—melanoma	0.00025	0.000287	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—S100B—melanoma	0.000249	0.000287	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CD—melanoma	0.000248	0.000285	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NOTCH1—melanoma	0.000248	0.000285	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CD80—melanoma	0.000242	0.000279	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KIT—melanoma	0.000242	0.000278	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—APC—melanoma	0.000242	0.000278	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CG—melanoma	0.000242	0.000278	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—NRAS—melanoma	0.000242	0.000278	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB4—melanoma	0.00024	0.000276	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CB—melanoma	0.00024	0.000275	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGF—melanoma	0.000239	0.000275	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB4—melanoma	0.000239	0.000274	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN2B—melanoma	0.000238	0.000274	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CB—melanoma	0.000238	0.000274	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN2B—melanoma	0.000237	0.000272	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAPK3—melanoma	0.000232	0.000266	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CD86—melanoma	0.00023	0.000265	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—CXCL8—melanoma	0.00023	0.000265	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CD86—melanoma	0.000229	0.000263	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—CXCL8—melanoma	0.000229	0.000263	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EDN1—melanoma	0.000229	0.000263	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—BRAF—melanoma	0.000228	0.000262	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EDN1—melanoma	0.000227	0.000261	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CSF2—melanoma	0.000223	0.000257	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGF1—melanoma	0.000223	0.000257	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CSF2—melanoma	0.000222	0.000255	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGF1—melanoma	0.000222	0.000255	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IGF1—melanoma	0.000222	0.000255	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—MAPK1—melanoma	0.000221	0.000254	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—EGFR—melanoma	0.000221	0.000254	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—IL2—melanoma	0.00022	0.000253	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—E2F1—melanoma	0.000219	0.000251	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—IL2—melanoma	0.000219	0.000251	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CB—melanoma	0.000218	0.00025	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—E2F1—melanoma	0.000217	0.00025	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PDGFRA—melanoma	0.000216	0.000249	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CB—melanoma	0.000216	0.000248	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PDGFRA—melanoma	0.000215	0.000247	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ITGB3—melanoma	0.000214	0.000246	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PRKCA—melanoma	0.000214	0.000246	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAP2K1—melanoma	0.000214	0.000246	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CD—melanoma	0.000213	0.000245	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PRKCA—melanoma	0.000213	0.000244	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ITGB3—melanoma	0.000213	0.000244	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—PIK3CA—melanoma	0.000211	0.000242	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—SPP1—melanoma	0.00021	0.000241	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAP2K2—melanoma	0.000209	0.000241	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—CXCL8—melanoma	0.000209	0.00024	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—SPP1—melanoma	0.000209	0.00024	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—KRAS—melanoma	0.000208	0.000239	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAP2K2—melanoma	0.000208	0.000239	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—CXCL8—melanoma	0.000208	0.000239	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—FGF2—melanoma	0.000204	0.000234	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL2—melanoma	0.0002	0.00023	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TERT—melanoma	0.000199	0.000229	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—RAC1—melanoma	0.000199	0.000228	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL2—melanoma	0.000198	0.000228	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TERT—melanoma	0.000198	0.000227	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—RAC1—melanoma	0.000197	0.000227	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—PIK3CA—melanoma	0.000191	0.00022	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MDM2—melanoma	0.000191	0.000219	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HIF1A—melanoma	0.00019	0.000219	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HIF1A—melanoma	0.000189	0.000217	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—ERBB2—melanoma	0.000188	0.000216	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CB—melanoma	0.000185	0.000213	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KDR—melanoma	0.000182	0.000209	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KDR—melanoma	0.000181	0.000208	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CXCL8—melanoma	0.000178	0.000205	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—HRAS—melanoma	0.000177	0.000204	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FN1—melanoma	0.000175	0.000202	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FN1—melanoma	0.000174	0.0002	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1B—melanoma	0.000174	0.0002	CbGpPWpGaD
Terlipressin—AVPR1B—GPCR downstream signaling—AKT1—melanoma	0.000172	0.000198	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NOTCH1—melanoma	0.000172	0.000197	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CASP3—melanoma	0.000171	0.000196	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL2—melanoma	0.00017	0.000196	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NOTCH1—melanoma	0.00017	0.000196	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—IL6—melanoma	0.000169	0.000195	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CD80—melanoma	0.000168	0.000193	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—APC—melanoma	0.000168	0.000193	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KIT—melanoma	0.000168	0.000193	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CG—melanoma	0.000168	0.000193	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—NRAS—melanoma	0.000168	0.000193	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CD80—melanoma	0.000167	0.000192	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—APC—melanoma	0.000167	0.000191	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CG—melanoma	0.000167	0.000191	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KIT—melanoma	0.000167	0.000191	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—NRAS—melanoma	0.000167	0.000191	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CCND1—melanoma	0.000166	0.000191	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGF—melanoma	0.000166	0.000191	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGF—melanoma	0.000165	0.000189	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CTNNB1—melanoma	0.000164	0.000189	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MMP9—melanoma	0.000161	0.000185	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAPK3—melanoma	0.000161	0.000185	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—CDKN1A—melanoma	0.000161	0.000185	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PTEN—melanoma	0.00016	0.000184	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAPK3—melanoma	0.00016	0.000183	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NFKB1—melanoma	0.000159	0.000183	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—BRAF—melanoma	0.000158	0.000181	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—BRAF—melanoma	0.000157	0.00018	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling by GPCR—AKT1—melanoma	0.000156	0.00018	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IGF1—melanoma	0.000154	0.000177	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—MAPK1—melanoma	0.000153	0.000176	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—EGFR—melanoma	0.000153	0.000176	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IGF1—melanoma	0.000153	0.000175	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—MAPK1—melanoma	0.000152	0.000174	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—EGFR—melanoma	0.000152	0.000174	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAP2K1—melanoma	0.000148	0.000171	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CD—melanoma	0.000147	0.00017	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAP2K1—melanoma	0.000147	0.000169	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CD—melanoma	0.000146	0.000168	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—PIK3CA—melanoma	0.000146	0.000168	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—PIK3CA—melanoma	0.000145	0.000167	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—VEGFA—melanoma	0.000145	0.000166	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—KRAS—melanoma	0.000144	0.000166	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—KRAS—melanoma	0.000143	0.000165	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—STAT3—melanoma	0.000143	0.000165	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—NRAS—melanoma	0.000143	0.000164	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—FGF2—melanoma	0.000141	0.000162	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—FGF2—melanoma	0.00014	0.000161	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK3—melanoma	0.000137	0.000157	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MYC—melanoma	0.000133	0.000153	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—PIK3CA—melanoma	0.000133	0.000153	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MDM2—melanoma	0.000132	0.000152	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—PIK3CA—melanoma	0.000132	0.000151	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MDM2—melanoma	0.000131	0.000151	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—MAPK1—melanoma	0.00013	0.00015	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—EGFR—melanoma	0.00013	0.00015	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—ERBB2—melanoma	0.00013	0.00015	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—ERBB2—melanoma	0.000129	0.000149	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CB—melanoma	0.000129	0.000148	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CB—melanoma	0.000128	0.000147	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CXCL8—melanoma	0.000124	0.000142	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—KRAS—melanoma	0.000123	0.000141	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—HRAS—melanoma	0.000123	0.000141	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CXCL8—melanoma	0.000123	0.000141	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—HRAS—melanoma	0.000122	0.00014	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1B—melanoma	0.000121	0.000139	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1B—melanoma	0.00012	0.000138	CbGpPWpGaD
Terlipressin—AVPR1A—GPCR downstream signaling—AKT1—melanoma	0.000119	0.000137	CbGpPWpGaD
Terlipressin—AVPR2—GPCR downstream signaling—AKT1—melanoma	0.000118	0.000136	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CASP3—melanoma	0.000118	0.000136	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL2—melanoma	0.000118	0.000136	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—IL6—melanoma	0.000117	0.000135	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CASP3—melanoma	0.000117	0.000135	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL2—melanoma	0.000117	0.000135	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—IL6—melanoma	0.000117	0.000134	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CCND1—melanoma	0.000115	0.000132	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CCND1—melanoma	0.000114	0.000131	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CTNNB1—melanoma	0.000114	0.000131	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CTNNB1—melanoma	0.000113	0.00013	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—PIK3CA—melanoma	0.000113	0.00013	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MMP9—melanoma	0.000112	0.000128	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—CDKN1A—melanoma	0.000111	0.000128	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PTEN—melanoma	0.000111	0.000128	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MMP9—melanoma	0.000111	0.000128	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NFKB1—melanoma	0.000111	0.000127	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—CDKN1A—melanoma	0.000111	0.000127	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PTEN—melanoma	0.00011	0.000127	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NFKB1—melanoma	0.00011	0.000126	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—TP53—melanoma	0.000109	0.000126	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling by GPCR—AKT1—melanoma	0.000108	0.000125	CbGpPWpGaD
Terlipressin—AVPR2—Signaling by GPCR—AKT1—melanoma	0.000108	0.000124	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—HRAS—melanoma	0.000105	0.00012	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—VEGFA—melanoma	0.0001	0.000115	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—IL6—melanoma	0.0001	0.000115	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—VEGFA—melanoma	9.96e-05	0.000115	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—STAT3—melanoma	9.94e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—NRAS—melanoma	9.91e-05	0.000114	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—STAT3—melanoma	9.86e-05	0.000113	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—NRAS—melanoma	9.84e-05	0.000113	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK3—melanoma	9.49e-05	0.000109	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK3—melanoma	9.42e-05	0.000108	CbGpPWpGaD
Terlipressin—AVPR1B—Signaling Pathways—AKT1—melanoma	9.24e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MYC—melanoma	9.23e-05	0.000106	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MYC—melanoma	9.17e-05	0.000105	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—MAPK1—melanoma	9.03e-05	0.000104	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—EGFR—melanoma	9.03e-05	0.000104	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—MAPK1—melanoma	8.97e-05	0.000103	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—EGFR—melanoma	8.96e-05	0.000103	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—KRAS—melanoma	8.53e-05	9.81e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—KRAS—melanoma	8.47e-05	9.74e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—PIK3CA—melanoma	7.84e-05	9.01e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—PIK3CA—melanoma	7.78e-05	8.94e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—TP53—melanoma	7.58e-05	8.72e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—TP53—melanoma	7.53e-05	8.65e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—HRAS—melanoma	7.25e-05	8.34e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—HRAS—melanoma	7.2e-05	8.28e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—IL6—melanoma	6.94e-05	7.98e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—IL6—melanoma	6.89e-05	7.92e-05	CbGpPWpGaD
Terlipressin—AVPR1A—Signaling Pathways—AKT1—melanoma	6.4e-05	7.36e-05	CbGpPWpGaD
Terlipressin—AVPR2—Signaling Pathways—AKT1—melanoma	6.36e-05	7.31e-05	CbGpPWpGaD
